CClinicalTrials.gg
RecruitingNCT06648707Updated Dec 6, 2024

Dual-task Training to Prevent Cognitive Decline in Community-dwelling Older Adults: A Pilot Pragmatic RCT

An interventional study of Dual-task training in Community-dwelling Seniors, sponsored by The University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-06.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Oct 2024; still recruiting 1 year 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Objectives:

This study aims to explore the feasibility and acceptance of group-based dual-task training for prevention of cognitive decline in a pragmatic setting for community-dwelling older adults.

The primary objective is to assess recruitment rate, attendance rate, retention rate and satisfaction rate of participants.

Study design and participants:

This is a pilot pragmatic RCT with waitlist control. First, a co-design approach will be adopted to develop the intervention with the older adults. Then, about six participating community centres will nominate staff or volunteer to receive the training in order to lead the intervention. Informed consent will be sought from the participants and baseline assessment will be conducted. The participants will be randomly allocated to the intervention and control groups in 1:1 ratio using block randomisation with varying block size. At the end of the study, one representative of each participating centre will be invited to provide qualitative feedback.

Measurements:

The primary outcomes are the feasibility outcomes, namely the recruitment rate, attendance rate, the retention rate, and satisfaction rate of participants. Secondary outcomes include completion rate of the interventionist, time to recruit target sample size, factors influencing older adults' decision to participate and staff of the community centre to organise the activity, subjective memory complaints, working memory, executive function, and cognitive status of participants. A structured questionnaire will be used to collect quantitative outcomes related to effects and satisfaction. Qualitative feedback from representatives of the elderly community centres will be collected according to a semi-structured interview guide.

Expected results: The intervention is feasible and highly accepted by the participants and staff of the community centres. Potential effect-related outcomes are to be demonstrated.

02

Conditions studied

  • Community-dwelling Seniors

Keywords

  • dual-task
  • cognitive training
  • Older adults
  • train-the-trainer
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's planned enrollment of 93 is above the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

(i) aged 65 years and above,

(ii) eligible to enrol in activities organised by the community centres,

(iii) no communication problems,

(iv) able to understand and follow instructions,

(v) able to read and write Chinese.

Exclusion criteria

Exclusion Criteria:

contraindications to chair-based or stepping exercises.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
93 participants (estimated)

Study arms

  • Other
    Assigned intervention

    The intervention group will start 6 week dual-task invention immediately after baseline.

    Other: Dual-task training

  • Other
    Assigned waitlist control

    The control group will start 6 week dual-task invention after the follow-up assessment 6 weeks after baseline.

    Other: Dual-task training

Interventions

  • OtherDual-task training

    Participants will receive a one-hour face-to-face group-based dual-task training session twice a week for 6 weeks. Training included cognitive components and physical components to be conducted simultaneously.

06

What researchers measure

Primary outcomes

  1. Recruitment rate

    Recruitment rate is defined as the number of participants agreed to join the study before randomization divided by the number of potential participants who completed recruitment briefing.

    Time frame: After baseline, before randomization

  2. Attendance rate

    Attendance rate is defined as the number of attended intervention sessions collected in attendance log divided by the number of planned intervention sessions.

    Time frame: 6 weeks after baseline for intervention group, 12 weeks after baseline for waitlist control group.

  3. Retention rate

    Retention rate is defined as the number of participants completing the post-intervention assessment divided by the number of participants at baseline.

    Time frame: 6 weeks after baseline for intervention group, 12 weeks after baseline for waitlist control group.

  4. Satisfaction rate

    Satisfaction to the project will be measured by a question using 5-point Likert scale (very satisfactory to very unsatisfactory). Satisfaction rate is defined as the number of participants rating the intervention a score of ≥4 out of 5 divided by the number of participants started intervention.

    Time frame: 6 weeks after baseline for intervention group, 12 weeks after baseline for waitlist control group.

Secondary outcomes

  1. Completion rate of the interventionist

    The number of nominated staff/volunteers considered as completing the project divided by the total number of nominated staff/volunteers

    Time frame: End of study, up to 2 years

  2. Time to recruit target sample size

    The time needed to recruit target sample size is defined as the time taken to recruit required sample size in each centre.

    Time frame: Before baseline

  3. Factors influencing older adults' decision to participate and staff of the community centre to organise the activity

    Reasons of the older adults and staff of the community centres for joining or not joining the study

    Time frame: At the end of recruitment briefing, before baseline

  4. Change from baseline subjective memory complaints at 6 weeks

    Subjective memory complaints will be measured by the 27-item Memory Inventory in Chinese (Lui et al., 2006). Participants response on the frequency of complaints related to daily living in the past month, using 0 (none) to 4 (continuously). The scale ranges from 0 to 108, higher score indicates more memory complaints.

    Time frame: 6 weeks after baseline

  5. Change from baseline subjective memory complaints at 12 weeks

    Subjective memory complaints will be measured by the 27-item Memory Inventory in Chinese (Lui et al., 2006). Participants response on the frequency of complaints related to daily living in the past month, using 0 (none) to 4 (continuously). The scale ranges from 0 to 108, higher score indicates more memory complaints.

    Time frame: 12 weeks after baseline, only for waitlist control group

  6. Change from baseline working memory at 6 weeks

    Working memory will be measured by Digit Span Test (Leung et al., 2011). The participants will repeat the digits series which are gradually longer. In both the forward and the backward test, the longer the series, the better the condition.

    Time frame: 6 weeks after baseline

  7. Change from baseline working memory at 12 weeks

    Working memory will be measured by Digit Span Test (Leung et al., 2011). The participants will repeat the digits series which are gradually longer. In both the forward and the backward test, the longer the series, the better the condition.

    Time frame: 12 weeks after baseline, only for waitlist control group

  8. Change from baseline executive function at 6 weeks

    Executive function will be measured by Chinese version of the Victoria Stroop Test (Lee and Chan, 2000). The completion time and number of errors that the participants made in naming the colour in the presence of different stimuli (number dots, words unrelated to color, words related to color) will be recorded, with more time and errors as worse condition.

    Time frame: 6 weeks after baseline

  9. Change from baseline executive function at 12 weeks

    Executive function will be measured by Chinese version of the Victoria Stroop Test (Lee and Chan, 2000). The completion time and number of errors that the participants made in naming the colour in the presence of different stimuli (number dots, words unrelated to color, words related to color) will be recorded, with more time and errors as worse condition.

    Time frame: 12 weeks after baseline, only for waitlist control group

  10. Change from baseline cognitive status at 6 weeks

    Cognitive status will be measured by the Montreal Cognitive Assessment 5-Minutes (Hong Kong Version) (HK-MoCA 5-Min) protocol. The validated assessment test covers four domains: attention, executive functions/language, orientation, and memory (Yeung et al., 2014). The total score ranges from 0 to 30; a higher score indicates better cognitive status.

    Time frame: 6 weeks after baseline

  11. Change from baseline cognitive status at 12 weeks

    Cognitive status will be measured by the Montreal Cognitive Assessment 5-Minutes (Hong Kong Version) (HK-MoCA 5-Min) protocol. The validated assessment test covers four domains: attention, executive functions/language, orientation, and memory (Yeung et al., 2014). The total score ranges from 0 to 30; a higher score indicates better cognitive status.

    Time frame: 12 weeks after baseline, only for waitlist control group

  12. Qualitative feedback

    Qualitative feedback on facilitators and barriers of organising the activity will be collected from one representative of each participating centre by semi-structured interview.

    Time frame: At the end of the study, up to 2 years

07

Study locations

1 of 1 sites recruiting
  • Community centre
    Hong Kong, Hong Kong
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06648707
Lead sponsor
The University of Hong Kong
Collaborators
Health and Medical Research Fund
Responsible party
Dr. Pui-Hing Chau (Associate Professor, The University of Hong Kong) — Principal investigator
First posted
Oct 18, 2024
Start date
Oct 21, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Dec 6, 2024

Study contacts

Pui Hing Chau, PhD
Contact
phpchau@hku.hk
3917 6626
Pui Hing Chau, PhD
principal investigator · School of Nursing, The University of Hong Kong

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion